AETHER: Q1 FY2027 delivered robust growth, margin expansion, and a landmark Dow Chemical R&D partnership

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Q1 FY2027 saw 27% revenue and 33% PAT growth year-over-year, driven by strong CEM/CRAMS performance and new product launches. Major expansion projects are on track, and a landmark R&D partnership with Dow Chemical positions the company for leadership in advanced silicones and semiconductor materials.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Q1 FY2027 saw 27% revenue and 33% PAT growth year-over-year, driven by strong CEM/CRAMS performance and new product launches. Major expansion projects are on track, and a landmark R&D partnership with Dow Chemical positions the company for leadership in advanced silicones and semiconductor materials.

Based on

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Source: Quartr The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.